From Raman to SESORRS : moving deeper into cancer detection and treatment monitoring

Sloan-Dennison, Sian and Laing, Stacey and Graham, Duncan and Faulds, Karen (2021) From Raman to SESORRS : moving deeper into cancer detection and treatment monitoring. Chemical Communications, 57 (93). pp. 12436-12451. ISSN 1359-7345

[thumbnail of Sloan-Dennison-etal-CC-2021-From-Raman-to-SESORRS-moving-deeper-into-cancer-detection-and-treatment-monitoring]
Preview
Text. Filename: Sloan_Dennison_etal_CC_2021_From_Raman_to_SESORRS_moving_deeper_into_cancer_detection_and_treatment_monitoring.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (3MB)| Preview

    Abstract

    Raman spectroscopy is a non-invasive technique that allows specific chemical information to be obtained from various types of sample. The detailed molecular information that is present in Raman spectra permits monitoring of biochemical changes that occur in diseases, such as cancer, and can be used for the early detection and diagnosis of the disease, for monitoring treatment, and to distinguish between cancerous and non-cancerous biological samples. Several techniques have been developed to enhance the capabilities of Raman spectroscopy by improving detection sensitivity, reducing imaging times and increasing the potential applicability for in vivo analysis. The different Raman techniques each have their own advantages that can accommodate the alternative detection formats, allowing the techniques to be applied in several ways for the detection and diagnosis of cancer. This feature article discusses the various forms of Raman spectroscopy, how they have been applied for cancer detection, and the adaptation of the techniques towards their use for in vivo cancer detection and in clinical diagnostics. Despite the advances in Raman spectroscopy, the clinical application of the technique is still limited and certain challenges must be overcome to enable clinical translation. We provide an outlook on the future of the techniques in this area and what we believe is required to allow the potential of Raman spectroscopy to be achieved for clinical cancer diagnostics.

    ORCID iDs

    Sloan-Dennison, Sian ORCID logoORCID: https://orcid.org/0000-0003-2473-1425, Laing, Stacey ORCID logoORCID: https://orcid.org/0000-0001-5781-349X, Graham, Duncan ORCID logoORCID: https://orcid.org/0000-0002-6079-2105 and Faulds, Karen ORCID logoORCID: https://orcid.org/0000-0002-5567-7399;